Tag: Relugolix

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Relugolix

Relief for Women: FDA Approves Heavy Menstrual Bleeding Drug

Added to Collection on: 2021-05-27 14:59:25

Tags for this article:

Drugs
Clinical medicine
Medicine
GnRH antagonists
Ethers
Triketones
Progestogens
Menstrual cycle
Relugolix
Uterine fibroid
Vaginal bleeding
Menstruation

Click the tags to see associated articles and topics

View Article Details
FDA Action Alert: Alkermes, Myovant & Pfizer, Scynexi and Liminal

Added to Collection on: 2021-06-01 13:02:46

Tags for this article:

Drugs
Receptor antagonists
Chemical compounds
Food and Drug Administration
Opioid antagonists
Atypical antipsychotics
Muscarinic antagonists
Dopamine antagonists
Olanzapine/samidorphan
Samidorphan
Alkermes
Relugolix

Click the tags to see associated articles and topics

View Article Details
Short Interest in Myovant Sciences Ltd. (NYSE:MYOV) Increases By 33.7%

Added to Collection on: 2021-07-03 13:18:45

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Corporate finance
Roivant Sciences
Stock
Share
Short
Relugolix
Citigroup
Myovant Sciences Ltd.

Click the tags to see associated articles and topics

View Article Details
FDA Makes Pfizer, Myovant Wait on Approval For Myfembree | BioSpace

Added to Collection on: 2022-05-06 13:45:12

Tags for this article:

Drugs
Menstrual cycle
Organ systems
Chemical compounds
Midwifery
Endometriosis
Ethers
GnRH antagonists
Triketones
Menstruation
Dysmenorrhea
Relugolix
Myovant
Pfizer
Myovant Sciences

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences (NYSE:MYOV) PT Raised to $10.00 at The Goldman Sachs Group

Added to Collection on: 2022-07-30 14:02:02

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Roivant Sciences
Stock
Short
Relugolix
Price?earnings ratio
Share
Myovant Sciences Ltd.

Click the tags to see associated articles and topics

View Article Details
FDA approves Myfembree for management of endometriosis pain - Healio

Added to Collection on: 2022-08-08 19:49:20

Tags for this article:

Drugs
Chemical compounds
Chemistry
RTT
Ethers
GnRH antagonists
Triketones
Endometriosis
Menstrual cycle
Email
Relugolix
Medroxyprogesterone acetate

Click the tags to see associated articles and topics

View Article Details
Myovant & Pfizer's MyFembree receives nod from the FDA for endometriosis

Added to Collection on: 2022-08-11 10:54:07

Tags for this article:

Hormones
Chemistry
Chemical compounds
GnRH antagonists
Ethers
Triketones
RTT
Antiandrogens
Elagolix
Endometriosis
Gonadotropin-releasing hormone antagonist
Relugolix
Pfizer

Click the tags to see associated articles and topics

View Article Details
Myovant Sciences rejects $2.5bn takeover bid from Sumitomo Pharma

Added to Collection on: 2022-10-13 10:35:17

Tags for this article:

Hormones
Chemical compounds
Organic compounds
GnRH antagonists
Ethers
Triketones
RTT
Estranes
Elagolix
Endometriosis
Relugolix
Gonadotropin-releasing hormone antagonist
Myovant
Myovant Sciences
sumitomo pharma

Click the tags to see associated articles and topics

View Article Details
A Win for Women With Symptomatic Uterine Fibroids - Medscape

Added to Collection on: 2022-12-14 17:31:02

Tags for this article:

Hormones
Organ systems
Sex hormones
RTT
Ethers
GnRH antagonists
Triketones
Benign neoplasms
Gonadotropin-releasing hormone antagonist
Elagolix
Relugolix
Heavy menstrual bleeding

Click the tags to see associated articles and topics

View Article Details
Sumitomo Pharma and Pfizer Canada Announce Availability of MYFEMBREE® in ... - Newswire.ca

Added to Collection on: 2024-01-31 18:31:04

Tags for this article:

Menstrual disorders
Endometriosis
Benign neoplasms
GnRH antagonists
Anatomical pathology
Uterine fibroid
Heavy menstrual bleeding
Dysmenorrhea
Leiomyoma
Medroxyprogesterone acetate
Relugolix
Adenomyosis
Sumitomo Pharma Canada Inc.
Sumitomo Pharma Co., Ltd.
Canada
Pfizer Canada ULC

Click the tags to see associated articles and topics

View Article Details